Guangzhou Wondfo Biotech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 21.14%

Guangzhou Wondfo Biotech Co Ltd (300482) has an Asset Resilience Ratio of 21.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Guangzhou Wondfo Biotech Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.41 Billion

≈ $205.81 Million USD Cash + Short-term Investments

Total Assets

CN¥6.65 Billion

≈ $973.47 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Guangzhou Wondfo Biotech Co Ltd's Asset Resilience Ratio has changed over time. See Guangzhou Wondfo Biotech Co Ltd book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Wondfo Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou Wondfo Biotech Co Ltd (300482) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.41 Billion	21.14%
Total Liquid Assets	CN¥1.41 Billion	21.14%

Asset Resilience Insights

Good Liquidity Position: Guangzhou Wondfo Biotech Co Ltd maintains a healthy 21.14% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Guangzhou Wondfo Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou Wondfo Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for Guangzhou Wondfo Biotech Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Wondfo Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	18.26%	CN¥1.31 Billion ≈ $191.15 Million	CN¥7.15 Billion ≈ $1.05 Billion	+5.74pp
2023-12-31	12.52%	CN¥722.45 Million ≈ $105.72 Million	CN¥5.77 Billion ≈ $844.58 Million	-2.37pp
2022-12-31	14.89%	CN¥938.07 Million ≈ $137.27 Million	CN¥6.30 Billion ≈ $922.05 Million	+3.09pp
2021-12-31	11.79%	CN¥572.73 Million ≈ $83.81 Million	CN¥4.86 Billion ≈ $710.56 Million	+9.41pp
2020-12-31	2.38%	CN¥102.60 Million ≈ $15.01 Million	CN¥4.31 Billion ≈ $630.12 Million	-1.00pp
2019-12-31	3.38%	CN¥99.50 Million ≈ $14.56 Million	CN¥2.94 Billion ≈ $430.80 Million	+4.04pp
2018-12-31	-0.66%	CN¥-17.66 Million ≈ $-2.58 Million	CN¥2.69 Billion ≈ $393.85 Million	+2.28pp
2017-12-31	-2.94%	CN¥-49.75 Million ≈ $-7.28 Million	CN¥1.69 Billion ≈ $248.00 Million	-2.93pp
2016-12-31	-0.01%	CN¥-69.38K ≈ $-10.15K	CN¥1.01 Billion ≈ $147.17 Million	+0.00pp
2015-12-31	-0.01%	CN¥-60.83K ≈ $-8.90K	CN¥798.57 Million ≈ $116.86 Million	--

pp = percentage points

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices

Market Cap

$1.25 Billion

CN¥8.56 Billion CNY

Market Cap Rank

#8139 Global

#2057 in China

Share Price

CN¥18.29

Change (1 day)

-1.93%

52-Week Range

CN¥17.43 - CN¥25.56

All Time High

CN¥92.01